Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Other Non-Current Liabilities: 2020-2024

Historic Other Non-Current Liabilities for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Dec 2024 value amounting to $52.5 million.

  • Maravai Lifesciences Holdings' Other Non-Current Liabilities fell 29.99% to $38.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.0 million, marking a year-over-year decrease of 29.99%. This contributed to the annual value of $52.5 million for FY2024, which is 11.81% down from last year.
  • Maravai Lifesciences Holdings' Other Non-Current Liabilities amounted to $52.5 million in FY2024, which was down 11.81% from $59.5 million recorded in FY2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Other Non-Current Liabilities ranged from a high of $69.0 million in FY2022 and a low of $2.2 million during FY2020.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $59.5 million (2023), whereas its average is $60.3 million.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Other Non-Current Liabilities spiked by 1,740.70% in 2021 and then fell by 13.75% in 2023.
  • Yearly analysis of 5 years shows Maravai Lifesciences Holdings' Other Non-Current Liabilities stood at $2.2 million in 2020, then spiked by 1,740.70% to $41.1 million in 2021, then soared by 67.96% to $69.0 million in 2022, then declined by 13.75% to $59.5 million in 2023, then dropped by 11.81% to $52.5 million in 2024.